Confusion

VOYDEYA™ approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular hemolysis in adults with the rare disease PNH

Retrieved on: 
Monday, April 1, 2024
Biotechnology, FDA, Health, Pharmaceutical, Clinical Trials, Factor D, Arthralgia, Chest pain, Confusion, Neuropsychological test, Infection, Eculizumab, Risk, Headache, ALPHA, PNH, C5, Patient, Orphan, Mitigation, Vaccine, Light, Paroxysmal nocturnal hemoglobinuria, EVH, Bacteria, University, Chills, MD, Breakthrough therapy, Cough, European Medicines Agency, Fatigue, Nausea, Rash, Fever, Priority, Safety, Immune system, REMS, Division, Vomiting, Hematology, Patient safety, Medicine

VOYDEYA has also been granted Orphan Drug Designation in the US, European Union (EU) and Japan for the treatment of PNH.

Key Points: 
  • VOYDEYA has also been granted Orphan Drug Designation in the US, European Union (EU) and Japan for the treatment of PNH.
  • You must complete or update meningococcal vaccine(s) and streptococcus vaccine(s) at least 2 weeks before your first dose of VOYDEYA.
  • If you have been vaccinated against these bacteria in the past, you might need additional vaccinations before starting VOYDEYA.
  • Carry it with you at all times during treatment and for 1 week after your last VOYDEYA dose.

CDK Bridges Longstanding Gap Between OEM and Dealer Shopping Experiences With Automotive Commerce Collab

Retrieved on: 
Tuesday, March 26, 2024
Technology, Other Retail, Automotive, Automotive Manufacturing, Specialty, Other Automotive, Software, Manufacturing, Retail, Artificial Intelligence, Friction, Documentation, Confusion, International Auto Show, Original equipment manufacturer, Partnership, Trust, Hyundai Motor America, CDK, OEM, Heart, Ecosystem, API, Hyundai, Multimedia, Frustration, Online shopping

View the full release here: https://www.businesswire.com/news/home/20240326270392/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240326270392/en/
    CDK Automotive Commerce Collab (Graphic: Business Wire)
    Thanks to a new initiative from CDK , the industry’s leading retail software provider, a remedy for these pain points is now available.
  • Power Auto Forum during the 2024 New York International Auto Show, the new Automotive Commerce Collab from CDK uses open and universal technology and application programming interfaces (APIs) to better connect OEM and dealer software.
  • The Automotive Commerce Collab is a game changer for everyone.”
    A better retail experience also empowers OEMs to have more control of their brand as consumers move fluidly among the OEM website, dealer website and in-store experience, according to their individual journeys.
  • For more information on the Automotive Commerce Collab initiative, please visit https://www2.cdkglobal.com/commerce-collab .

United Kingdom Social Commerce Market Databook 2024-2029: Social Media Platforms have Emerged as a Strong Revenue Generator for Smaller Businesses - ResearchAndMarkets.com

Retrieved on: 
Monday, March 18, 2024
Luxury, Other Retail, Supermarket, Consumer, Food, Beverage, Fashion, Retail, Lodging, Travel, Small Business, Public Relations, Investor Relations, Millennials, Marketing, Communications, Generation Z, Professional Services, Social Media, Home Goods, Other Consumer, Online Retail, EMarketer, Algorithm, Confusion, Growth, Klarna, Social commerce, Meta, Social media, Operational definition, Commerce, Traction

The social commerce market is poised to grow at a steady rate over the medium term in the United Kingdom.

Key Points: 
  • The social commerce market is poised to grow at a steady rate over the medium term in the United Kingdom.
  • Small businesses, in the United Kingdom, are increasingly making use of social channels to reach their targeted customers.
  • Overall, a positive growth outlook is expected for the social commerce market over the next three to four years in the United Kingdom.
  • This shows that while Meta is dominating the social commerce market in the United Kingdom, TikTok is gaining ground rapidly among social buyers.

Businessolver Data Reveals How AI and Human Empathy Revolutionize Employee Benefits Engagement

Retrieved on: 
Thursday, March 14, 2024
Technology, Health, Insurance, Human Resources, Finance, Consulting, Personal Finance, Professional Services, Artificial Intelligence, Other Technology, Software, Data Analytics, Health Technology, Data Management, Automation, Organization, Face, Confusion, Empathy, Somatosensory system, Artificial intelligence, AI, Waste, Human Touch, Customer service

Businessolver ® has unveiled its much-anticipated 2024 Benefits Insights Report today, marking a significant contribution to the understanding of employee benefits trends, challenges, and the expanding role of artificial intelligence (AI) and personalization in enhancing the benefits experience.

Key Points: 
  • Businessolver ® has unveiled its much-anticipated 2024 Benefits Insights Report today, marking a significant contribution to the understanding of employee benefits trends, challenges, and the expanding role of artificial intelligence (AI) and personalization in enhancing the benefits experience.
  • Data from the Benefitsolver™ platform, Businessolver’s benefits administration technology, which serves over 18 million people, reveals quantitative proof that AI and personalized experiences improve overall benefits engagement and plan performance.
  • AI and Personalization: AI-driven personalization doubles benefits engagement, resulting in right-fit plan elections, right-time benefits utilization, increased year-round engagement, and successful issue resolutions that stay resolved for 7+ days.
  • The Human Touch: Alongside the positive impact of AI, the report underscores the irreplaceable value of human interaction in benefits, signaling that the most effective and successful AI events in benefits are born from a harmonious blend of human empathy and technology.

Valer Partners with Encoda to Improve End-to-End Revenue Cycle Management

Retrieved on: 
Wednesday, March 13, 2024
Payments, Data Management, Health, Technology, Practice Management, Managed Care, Software, Partnership, Hughes, Automation, Confusion, Entrepreneurship, Pharmaceutical industry

For Valer clients, the benefit of this partnership will result in faster, simpler, and less expensive prior authorization workflows, which reduces errors that can lead to claim denials on the back end of the revenue cycle.

Key Points: 
  • For Valer clients, the benefit of this partnership will result in faster, simpler, and less expensive prior authorization workflows, which reduces errors that can lead to claim denials on the back end of the revenue cycle.
  • “We’re thrilled to announce this partnership with Encoda,” states Dr. Steve Kim, Co-Founder and CEO of Valer.
  • “Partnering with Valer feels like a natural extension of Encoda’s mission,” notes Lisa Taylor, CEO of Encoda.
  • We are eager to see how our combined solutions drive significant advancements for revenue cycle leaders.”
    For more information about how Valer addresses the industry’s most pressing prior authorization challenges, visit https://valer.health/prior-authorizations/ .

New HES Report: The Truth About 10,000 Steps a Day

Retrieved on: 
Tuesday, March 12, 2024
Mental Health, Research, Human Resources, Professional Services, Other Education, Health, General Health, Science, Education, Steps, Death, Cardiovascular disease, Job satisfaction, Confusion, HES, Social support, Risk, White paper, Cancer, Gold, Multimedia, Dementia, Management

View the full release here: https://www.businesswire.com/news/home/20240312637494/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240312637494/en/
    Thumbnail of white paper - The Truth About 10,000 Steps A Day (Photo: Business Wire)
    “10,000 steps a day has been a popular recommendation for decades, but some confusion and misinformation have surrounded its validity,” explains lead author and employee well-being consultant Bob Merberg.
  • It also highlights a link between more steps, up to about 10,000, and a lower risk of cancer as well as cardiovascular disease.
  • In addition, the paper discusses a study result that associates 10,000 steps each day with lower risk of dementia.
  • “The research is clear — taking 10,000 steps a day has significant health benefits,” Bob emphasizes.

HEALTH GROUPS FILE SECOND LAWSUIT AGAINST THE US FDA

Retrieved on: 
Tuesday, April 2, 2024
Tobacco industry, Conference, Plaintiff, Confusion, ASH, Initiative, SAN, Public, Patient, Research, Black, Sale, Smoke, Chairperson, Life, Public health law, Smoking, Food, FDA, Court, Physician, NMA, National Medical Association, Tobacco

SAN FRANCISCO, April 2, 2024 /PRNewswire/ -- The African American Tobacco Control Leadership Council (AATCLC), Action on Smoking and Health (ASH), and the National Medical Association (NMA), represented by Christopher Leung of Leung Law PLLC, have filed a second lawsuit against the U.S. Food and Drug Administration (FDA) in the Northern District of California for the agency's inaction on issuing a final rule banning menthol cigarettes. This lawsuit comes more than seven months after the FDA's initial date for finalizing the new rule and follows the FDA's 15-year delay in equitable policymaking.

Key Points: 
  • The initial complaint sought to compel the FDA to act on its earlier conclusions that removing menthol cigarettes from the marketplace would benefit public health.
  • The joint lawsuit followed the 2013 Citizen Petition from the Public Health Law Center which called on the FDA to prohibit the sale of menthol cigarettes.
  • "We're extremely disappointed to be forced to file this second lawsuit against the FDA in support of protecting Americans from menthol cigarettes," said Laurent Huber, Executive Director of Action on Smoking and Health.
  • As a result of the Plaintiffs' first lawsuit, the FDA made the landmark determination to add menthol to the list of banned characterizing flavors in cigarettes.

Alliance Creative Group (ACGX) Releases 2023 Annual Financial and Disclosure Report - PeopleVine's revenue increased by 100% in 2023

Retrieved on: 
Monday, April 1, 2024
AP, Growth, Confusion, Risk, Sale, Acquisition, Disclosure, Wrigley Field, OTC, Investment, Hand, Net income

CHICAGO, April 1, 2024 /PRNewswire/ -- Alliance Creative Group, Inc., (http://www.ACGX.us) (OTC: ACGX) is pleased to announce the results of Operations for the Year Ending December 31, 2023.

Key Points: 
  • CHICAGO, April 1, 2024 /PRNewswire/ -- Alliance Creative Group, Inc. , ( http://www.ACGX.us ) (OTC: ACGX) is pleased to announce the results of Operations for the Year Ending December 31, 2023.
  • *The Company changed to Cash Basis accounting to avoid confusion with the delayed Peak Construction projects.
  • Paul Sorkin, CEO of the Alliance Creative Group, Inc. said, "Our potentially most valuable asset/investment (The PeopleVine shares) had its best year ever.
  • We will continue to update the public as things are finalized and will share more details as they become available."

Oracle NetSuite Supercharges the Suite with Expansion of Generative AI Capabilities

Retrieved on: 
Thursday, March 28, 2024
Customer support, HR, Organization, Confusion, RDMA, Accounting, NetSuite, OCI, AI, Human, Marketing, LLM, Oracle, Privacy, Collection, Movement, Cohere

NEW YORK, March 28, 2024 /PRNewswire/ -- SuiteConnect -- Oracle NetSuite today announced it is expanding its generative AI capabilities across the suite. NetSuite Text Enhance helps users leverage company-specific, relevant data to create and refine contextual and personalized content. Now embedded in more finance and accounting, supply chain and operations, sales and marketing, and customer support processes, NetSuite Text Enhance will help organizations reach their goals faster and more efficiently by increasing productivity, reducing human error, improving consistency, and accelerating business processes.

Key Points: 
  • Built on OCI and leveraging its leading AI services, the embedded NetSuite Text Enhance generative AI capabilities are designed to respect customers' enterprise data, privacy, and security.
  • With OCI Generative AI Service, no customer data is shared with large language model (LLM) providers or seen by other customers.
  • NetSuite Text Enhance generative AI services are powered by OCI, which hosts both prebuilt and custom models.
  • "The generative AI features in NetSuite are helping us be more productive while ensuring the content generated is correct," said Brian Wenzl, partner, Opal Creek Consulting.

InventHelp Inventor Develops Convenient Caffeine Indicator Device (DCD-340)

Retrieved on: 
Wednesday, March 27, 2024
Suite, Multimedia, Drinking, Confusion, Sale, Restaurant, Anxiety, Caffeine

My design would help eliminate the anxiety associated with guessing whether a drink was caffeinated or decaffeinated."

Key Points: 
  • My design would help eliminate the anxiety associated with guessing whether a drink was caffeinated or decaffeinated."
  • The patent-pending invention provides an effective means of determining whether a drink was caffeinated or decaffeinated.
  • In doing so, it allows the user to immediately know the level of caffeine within a drink before consumption.
  • 22-DCD-340, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext.